+
Site Tour

Clinical practice for Tavi : Long-term outcomes from valve design and implantation

Watch this session if you want to learn about new trends for TAVI in younger patients, understand concerns of TAVI in patients with longer life-expectancy and learn how valve design and implantation technique may influence long-term outcomes

Related Videos

PCR LV 23 - The Heart Team ring, Vol II

TAVI Summit - Cardiac imaging

PCR LV 2021: Navitor™

Now you've got Navitor.
Stable delivery.

Transcatheter Interventions 2022: Breakout

TAVI 2023: Younger patients

Navitor™: Voice of the Experts Mohammed Saad

TAVI 2023: Optimizing TAVI

Navitor™: Voice of the Experts Lars Sondergaard

TRENDING TOPICS

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

CONNEXT


HUB
RELATED RESOURCES

ESC 2021: HF & VHD Guidelines

PCR LV 2021: Navitor™ 30-day outcomes

EuroPCR 2022: TAVI 1yr outcomes

PCR LV 2021: Navitor™ Live-in-a-box

CONNEXT


LIVE
RELATED EVENTS

TAVI 2023: Calcified valve

TAVI Summit - What is coming next

TAVI Summit - Live case from Berlin

TAVI Summit - Cardiac imaging and morphology

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline